Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Chemotherapy (CT) & Acute myeloid leukemia (AML) (FLT3 m)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

For Acute myeloid leukemia (AML) (FLT3 m): Intensive treatment involves standard anthracycline–cytarabine chemotherapy with an added FLT3 inhibitor.
Short et al. 2023 Blood Cancer J 13: 142
Daver et al. 2021 Blood Cancer J 11(5): 104

…

References (Sources)

FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
Daver et al. 2021 Blood Cancer J 11(5): 104
Review
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
Perl et al. 2019 N Engl J Med 381: 1728-1740
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation
Ballesta-López et al. 2021 Future Oncoloy 17: 215–227
Review
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
Erba et al. 2023 The Lancet 401: 1571-1583
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation
Tzogani et al. 2020
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors
Short et al. 2023 Blood Cancer J 13: 142
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Chemotherapy (CT) & Acute myeloid leukemia (AML) (FLT3 m)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat